Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-033661
Filing Date
2022-09-16
Accepted
2022-09-16 18:05:13
Documents
2
Period of Report
2022-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1422
2 EXHIBIT 24 brhc10041953_ex24.htm EX-24 9901
  Complete submission text file 0001140361-22-033661.txt   12684
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVE. LEXINGTON MA 02421
Business Address
Knobil Katharine (Reporting) CIK: 0001768011 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39303 | Film No.: 221249007